Valuation Charles River Laboratories International, Inc.

Stocks

Market Closed - NYSE Other stock markets 01:30:03 12/06/2026 am IST			5-day change	1st Jan Change
188.06 ^USD	+0.95%		+1.22%	-5.72%

05/06	Charles River Laboratories Has Potential to Outperform in 2H 2026, RBC Says	MT
03/06	Charles River Laboratories International, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 09:55 AM

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	18,941	11,138	12,252	9,520	10,023	9,058	-	-
Change	-	-41.2%	10%	-22.3%	5.29%	-9.63%	-	-
Enterprise Value (EV) ¹	21,366	13,616	14,622	11,565	11,946	10,871	10,526	10,150
Change	-	-36.28%	7.39%	-20.91%	3.29%	-9%	-3.17%	-3.58%
P/E Ratio	49.4x	23.1x	25.9x	931x	-70x	30.7x	20.4x	18.7x
PBR	7.45x	3.75x	3.41x	2.75x	3.17x	2.75x	2.5x	2.27x
PEG	-	0.9x	-9.44x	-9.5x	0x	-0x	0.4x	1.98x
Capitalization / Revenue	5.35x	2.8x	2.97x	2.35x	2.5x	2.35x	2.31x	2.21x
EV / Revenue	6.04x	3.42x	3.54x	2.86x	2.98x	2.82x	2.68x	2.47x
EV / EBITDA	24.3x	13.7x	14.4x	11.6x	12.3x	11x	10.1x	9.13x
EV / EBIT	28.8x	16.3x	17.4x	14.3x	15x	13.4x	11.9x	10.7x
EV / FCF	40.2x	46.2x	40x	23.1x	23x	31.3x	26.8x	42.4x
FCF Yield	2.49%	2.17%	2.5%	4.34%	4.34%	3.2%	3.73%	2.36%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	7.6	9.48	9.22	0.2	-2.91	6.135	9.2	10.07
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	3,540	3,976	4,129	4,050	4,015	3,855	3,924	4,105
EBITDA ¹	879.5	990.9	1,013	996.1	971.5	986.4	1,046	1,111
EBIT ¹	742.1	834	838.8	805.9	793.9	813.2	881	947.2
Net income ¹	391	486.2	474.6	10.3	-144.3	285.1	417.2	449
Net Debt ¹	2,425	2,477	2,370	2,046	1,923	1,812	1,468	1,091
Reference price ²	375.34	218.92	238.84	186.16	203.66	188.06	188.06	188.06
Nbr of stocks (in thousands)	50,464	50,879	51,297	51,136	49,215	48,168	-	-
Announcement Date	16/02/22	22/02/23	14/02/24	19/02/25	18/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	30.37x	2.8x	10.93x	-.--%	897.32Cr
LONZA GROUP AG	30.13x	5.34x	16.55x	1.09%	4.37TCr
REVOLUTION MEDICINES, INC.	-18.13x	265.48x	-16.35x	-.--%	3.07TCr
IQVIA HOLDINGS INC.	22.17x	2.55x	11.02x	-.--%	3.04TCr
BEONE MEDICINES AG	39.33x	3.9x	24.96x	-.--%	2.93TCr
CELLTRION, INC.	28.27x	7.29x	18.77x	0.42%	2.42TCr
MEDPACE HOLDINGS, INC.	27.34x	4.38x	19.95x	-.--%	1.33TCr
EUROFINS SCIENTIFIC SE	22.72x	1.96x	8.62x	1.17%	1.32TCr
IONIS PHARMACEUTICALS, INC.	-20.47x	13.36x	-19.89x	-.--%	1.21TCr
Average	17.97x	34.12x	8.28x	0.3%	2.29TCr
Weighted average by Cap.	19.23x	43.77x	9.61x	0.36%